April 1, 2020
Nordic startup SideKickHealth is working with the COVID-19 response team in Iceland to provide its digital therapeutics platform to people who have been diagnosed with the virus.
Its platform allows the remote triaging and managing of large numbers of people in isolation, who self-report on a panel of symptoms and measurements via a smartphone app multiple times a day.
Patients are assessed via...
Ralf-Gordon Jahns (pictured on the right) is the Managing Director of Research2Guidance, a leading market analyst and strategy consultancy company for the global digital health market.
April 1, 2020
The coronavirus is spreading around the world exponentially. Governments, healthcare providers, and businesses are introducing drastic measures to slow down the spreading of the virus.
There is a strong belief among digital health providers that their services can be of great help now. There are already more than 800 million users of digital health services globally, including symptom checkers,...
March 30, 2020
These have been turbulent times for the FDA. On the one hand, the U.S. regulator has found itself carefully unravelling guidances to bolster COVID-19 testing and treatment – sometimes leading to confusion for companies searching for new ways to combat the global epidemic. On the other, the agency continues to push forward with broader initiatives to remap its processes so that novel software...
March 30, 2020
MyHeritage, a genealogy and health DNA testing company, has teamed up with the Beijing Genomics Institute (BGI) to establish a COVID-19 testing lab in its home country of Israel, the Jerusalem Post reported on Saturday. The facility is aiming to open its doors by April 9 with a 10,000-tests-per-day capacity, and hopes to scale up to 20,000 per day shortly after.
“BGI will ship to Israel in the...
March 27, 2020
Yesterday, Pear Therapeutics announced the regulatory clearance of Somryst, its prescription digital therapeutic for chronic insomnia. And while the product is noteworthy for these patients and Pear's broader business, it also stands as a major milestone for the digital health industry – the first product to be evaluated throught the FDA's Digital Health Software Precertification Program.
March 26, 2020
Pear Therapeutics announced this morning that Somryst, its prescription digital therapeutic for adults with chronic insomnia, has received marketing authorization from the FDA.
The treatment provides cognitive behavioral therapy for insomnia (CBTi) alongside personalized, algorithm-generated sleep restriction recommendations. The digital therapeutic was reviewed through the agency's 510(k)...
March 25, 2020
A Dubai-based entrepreneur has backed a British biotech research company currently working on an affordable vaccine to protect against COVID-19.
Khurram Shroff, chairman of the UAE’s IBC Group, has donated a total of AED 5 million ($1.36m) to Vaxbio, also joining the company as a strategic advisor to assist with the development and communication of its corporate initiatives.
Vaxbio, a research...
March 17, 2020
Yesterday a new digital pharmacy launched, dubbed Genius Rx. The new platform will include an artificial intelligence enabled patient engagement tool, which aims to make the experience more personalized, as well as a smart pricing function.
In part, the company said this is an effort to rebrand and automate Mailmyprescriptions.com, which will now be rolled into its pharmacy-as-a-service platform...